These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 34874839)

  • 1. Complex regional pain syndrome of the foot in a girl with post-SARS-CoV-2 chilblains.
    Peri F; Della Paolera S; Conversano E; Murru FM; Tommasini A; Taddio A
    Clin Exp Rheumatol; 2022 May; 40(5):1056-1057. PubMed ID: 34874839
    [No Abstract]   [Full Text] [Related]  

  • 2. Approach to Chilblains During the COVID-19 Pandemic [Formula: see text].
    Ladha MA; Luca N; Constantinescu C; Naert K; Ramien ML
    J Cutan Med Surg; 2020; 24(5):504-517. PubMed ID: 32741218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cutaneous lesions in COVID-19 patients].
    Çiftçi Z; Clabbers JMK; Galimont-Collen AFS; Gostyński A
    Ned Tijdschr Geneeskd; 2020 Dec; 164():. PubMed ID: 33332042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 Vaccination Safety in Patients who have had SARS-CoV-2-induced Chilblains.
    Poizeau F; Triquet L; Dupuy A
    Acta Derm Venereol; 2022 Jun; 102():adv00728. PubMed ID: 35506360
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluation of SARS-CoV-2 antibodies in 24 patients presenting with chilblains-like lesions during the COVID-19 pandemic.
    Stavert R; Meydani-Korb A; de Leon D; Osgood R; Blau J; Luu T
    J Am Acad Dermatol; 2020 Dec; 83(6):1753-1755. PubMed ID: 32822790
    [No Abstract]   [Full Text] [Related]  

  • 6. Case did not consider all potential causes of chilblains.
    Dewar CL
    CMAJ; 2020 Sep; 192(36):E1046. PubMed ID: 32900767
    [No Abstract]   [Full Text] [Related]  

  • 7. COVID-19 pandemic-associated chilblains: more links for SARS-CoV-2 and less evidence for high interferon type I systemic response.
    Bessis D; Trouillet-Assant S; Secco LP; Bardin N; Blanc B; Blatière V; Chable-Bessia C; Delfour C; Girard C; Richard JC; Gros N; Le Moing V; Molinari N; Pallure V; Pisoni A; Raison-Peyron N; Reynaud E; Schwob É; Pescarmona R; Samaran Q; Willems M; Vincent T; Sofonea MT; Belot A; Tuaillon É
    Br J Dermatol; 2022 Dec; 187(6):1032-1035. PubMed ID: 35971922
    [No Abstract]   [Full Text] [Related]  

  • 8. A case of onychomadesis associated with chilblain-like lesions after COVID-19 infection.
    Colonna C; Giacalone S; Zussino M; Monzani NA; Cambiaghi S; Cavalli R
    J Eur Acad Dermatol Venereol; 2022 Sep; 36(9):e668-e669. PubMed ID: 35535454
    [No Abstract]   [Full Text] [Related]  

  • 9. Auricle perniosis as a manifestation of Covid-19 infection.
    Proietti I; Tolino E; Bernardini N; Mambrin A; Balduzzi V; Marchesiello A; Michelini S; Del Borgo C; Skroza N; Lichtner M; Potenza C
    Dermatol Ther; 2020 Nov; 33(6):e14089. PubMed ID: 32720420
    [No Abstract]   [Full Text] [Related]  

  • 10. Dermatology and COVID-19: Much knowledge to date but still a lot to discover.
    Le Cleach L
    Ann Dermatol Venereol; 2021 Jun; 148(2):69-70. PubMed ID: 33781568
    [No Abstract]   [Full Text] [Related]  

  • 11. Pandemic chilblains: Are they SARS-CoV-2-related or not?
    De Greef A; Coulie PG; Baeck M
    Clin Immunol; 2022 Apr; 237():108984. PubMed ID: 35338000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognosis of rash and chilblain-like lesions among outpatients with COVID-19: a large cohort study.
    Mascitti H; Jourdain P; Bleibtreu A; Jaulmes L; Dechartres A; Lescure X; Yordanov Y; Dinh A;
    Eur J Clin Microbiol Infect Dis; 2021 Oct; 40(10):2243-2248. PubMed ID: 34255231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of association between pandemic chilblains and SARS-CoV-2 infection.
    Gehlhausen JR; Little AJ; Ko CJ; Emmenegger M; Lucas C; Wong P; Klein J; Lu P; Mao T; Jaycox J; Wang E; ; Ugwu N; Muenker C; Mekael D; Klein RQ; Patrignelli R; Antaya R; McNiff J; Damsky W; Kamath K; Shon J; Ring AM; Yildirim I; Omer S; Ko AI; Aguzzi A; Iwasaki A
    Proc Natl Acad Sci U S A; 2022 Mar; 119(9):. PubMed ID: 35217624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging Evidence of the Direct Association Between COVID-19 and Chilblains.
    Freeman EE; McMahon DE; Fox LP
    JAMA Dermatol; 2021 Feb; 157(2):238-239. PubMed ID: 33355601
    [No Abstract]   [Full Text] [Related]  

  • 15. Association between COVID-19 and chilblains: a case-control study.
    Ortega-Quijano D; Fernandez-Nieto D; Jimenez-Cauhe J; Cortes-Cuevas JL; Marcos-Mencia D; Rodriguez-Dominguez M; Segurado-Miravalles G; Fernandez-Guarino M; Jaen-Olasolo P
    J Eur Acad Dermatol Venereol; 2021 Jun; 35(6):e359-e361. PubMed ID: 33651424
    [No Abstract]   [Full Text] [Related]  

  • 16. Emerging Evidence of the Direct Association Between COVID-19 And Chilblains-Reply.
    Baeck M; Herman A
    JAMA Dermatol; 2021 Feb; 157(2):239-240. PubMed ID: 33355606
    [No Abstract]   [Full Text] [Related]  

  • 17. "COVID Toes" in Three Siblings.
    Feder HM
    Pediatr Infect Dis J; 2021 Dec; 40(12):e488-e490. PubMed ID: 34292264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19 skin manifestations: the new great imitator?
    Shi V; Hsiao JL; Shi VY
    Dermatol Online J; 2020 Nov; 26(11):. PubMed ID: 33342186
    [No Abstract]   [Full Text] [Related]  

  • 19. Chronic chilblain-like lesions occurring during the Covid pandemic: case series.
    Nathan J; Rastogi A; Kiely PDW
    Clin Exp Rheumatol; 2023 Nov; 41(11):2338. PubMed ID: 37279151
    [No Abstract]   [Full Text] [Related]  

  • 20. Chilblains and COVID-19: why SARS-CoV-2 endothelial infection is questioned.
    Baeck M; Hoton D; Marot L; Herman A
    Br J Dermatol; 2020 Dec; 183(6):1152-1153. PubMed ID: 32798309
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.